Skip to main content
Article Open Access

Crystal structure of 5,7,4′-trihydroxy-3,8,3′-trymethoxyflavone, C18H16O8

  • EMAIL logo , , , , and
Published/Copyright: February 7, 2017
Download Article (PDF)
Become an author with De Gruyter Brill
Submit Manuscript Author Information
Zeitschrift für Kristallographie - New Crystal Structures
From the journal Zeitschrift für Kristallographie - New Crystal Structures Volume 232 Issue 2

Abstract

C18H16O8, monoclinic, P21/n, (no. 14), a = 7.9253(3) Å, b = 16.8928(6) Å, c = 11.8439(5) Å, β = 92.387(2)°, V = 1584.29(11) Å3, Z = 4, Rgt(F) = 0.043, wRref(F2) = 0.102, T = 295(2) K.

CCDC no.:: 1526063

The asymmetric unit of the title crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.

Table 1

Data collection and handling.

Crystal:Yellow block
Size:0.30 × 0.22 × 0.14 mm
Wavelength:Mo Kα radiation (1.54178 Å)
μ:10.2 cm−1
Diffractometer, scan mode:Bruker AXS, φ and ω
2θmax, completeness:118.2°, >99%
N(hkl)measured, N(hkl)unique, Rint:32631, 2274, 0.089
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 1510
N(param)refined:242
Programs:SHELX [10], Bruker programs [11], OLEX2 [12] PLATON [13]
Table 2

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
O10.5544(2)0.66230(9)0.31502(14)0.0388(5)
O20.4170(2)0.52051(9)0.25114(15)0.0443(5)
O30.0958(2)0.52054(10)0.14519(18)0.0597(6)
H30.14710.48310.17440.090*
O40.0675(2)0.79701(10)0.15748(18)0.0539(6)
H40.12090.83530.18200.081*
O50.3169(2)0.87250(10)0.26028(16)0.0478(5)
O60.6286(2)0.87039(9)0.37013(15)0.0422(5)
O71.1846(2)0.80685(10)0.52927(17)0.0554(6)
O81.2827(2)0.65493(10)0.52644(17)0.0531(6)
H81.33110.69410.55290.080*
C1’0.8013(3)0.71289(14)0.4003(2)0.0342(6)
C2’0.9090(3)0.77182(15)0.4446(2)0.0393(7)
H2’0.87210.82410.44570.047*
C3’1.0688(3)0.75358(15)0.4867(2)0.0385(7)
C4’1.1240(3)0.67539(15)0.4881(2)0.0378(7)
C5’1.0176(3)0.61722(15)0.4478(2)0.0476(8)
H5’1.05300.56470.45040.057*
C6’0.8589(3)0.63525(15)0.4034(2)0.0438(7)
H6’0.78930.59490.37520.053*
C20.6344(3)0.73097(14)0.3490(2)0.0343(6)
C30.5555(3)0.80169(14)0.3315(2)0.0343(6)
C40.3905(3)0.80718(14)0.2762(2)0.0367(7)
C50.1549(3)0.72954(15)0.1825(2)0.0376(7)
C60.0870(3)0.65860(15)0.1502(2)0.0437(7)
H6−0.01690.65690.11080.052*
C70.1727(3)0.58862(15)0.1761(2)0.0400(7)
C80.3295(3)0.59027(13)0.2321(2)0.0350(6)
C90.3981(3)0.66317(14)0.2619(2)0.0325(6)
C100.3141(3)0.73404(13)0.2397(2)0.0332(6)
C160.4285(4)0.49738(16)0.3677(2)0.0574(9)
H16B0.51300.45700.37820.086*
H16A0.32130.47720.38950.086*
H16C0.45880.54240.41360.086*
C170.7073(4)0.91556(16)0.2842(3)0.0623(9)
H17C0.62660.92590.22330.093*
H17A0.80060.88620.25630.093*
H17B0.74740.96480.31560.093*
C181.1472(4)0.88914(15)0.5160(3)0.0551(8)
H18C1.11560.89980.43840.083*
H18A1.24520.91980.53790.083*
H18B1.05580.90310.56280.083*

Source of material

The title compound C18H16O8 was isolated using high speed countercurrent chromatography (HSCCC). Following our program to isolate components from the Atacama Desert Flora, Northern Chile [1], [2], [3], [4], dried aerial parts of Parastrephia quadrangularis (1622 g) collected in april 2015 in El Tatio, were defatted with hexane (3 liters, 3 times in the dark, 24 h each time) and 54.82 g were obtained after evaporation of the solvent. Then the plant material was extracted with ethyl acetate (3 liters, 3 times in the dark, 24 Hs each time. After evaporation of the solvent under vacuo at 35 oC, 485 g of a dark gummy extract was obtained. A portion of the extract (0.5 g) was filtered and submitted to a HSCCC centrifuge (Quattro MK-7, Bridgend, UK) for the separation of its components. The solvent system selected was the isocratic two-phase non aqueous solvent system: n-hexane: ethyl acetate: methanol: water 3:7:5:5 v/v/v provided the better K values for all major compounds (0.5 < K < 1.3). This system was previously used for the separation of terpenes [4]. After equilibration of the solvent system in a separatory funnel, the upper and lower working phases were separated and degassed in an ultrasonic bath for 15 min before use. The sample was prepared by dissolving 500 mg of exudate from P. quadrangularis in 5.0 mL of each phase of the solvent system, filtered and loaded into an injection valve (Rheodyne model 5010A) equipped with a 8 mL loop. The preparative coil (116 mL) was filled with the upper stationary phase and the apparatus was rotated at 850 rpm. The mobile lower phase was then pumped in a head-to-tail direction (H-T) at a flow rate of 5 mL/minute. After the mobile phase front emerged and the hydrodynamic equilibrium was established in the column, the percentage of the retention of the stationary phase (60%) was recorded. Then the sample was injected thorough the injection valve at a flow rate of 5 mL-minute. The fractions eluted were collected with the fraction collector (5 mL each) and analyzed by TLC (F254 Silica gel plates, developed with hexane : EtOAc, 1 : 1 v/v, and spots visualized by spraying with vanillin : sulfuric acid 2% in ethanol and heating. CCC rotation was interrupted in tube 70 and the coil content was collected (“wash-off”), originating 95 fractions of 6 mL each. After re-purification by sephadex LH 20 (solvent methanol), HSCCC fractions 12–18 afforded 11-p-coumaroyl-tremetone [5], (55 mg) fractions 23–29 umbelliferone [6] (12 mg) and fractions 35–38 the title compound (5, 7, 4′ trihydroxy-3,8,3′ trymethoxyflavone, 12 mg) for which NMR data are consistent with literature [7], [8], [9]. Recrystallization from ethyl acetate at −20° C yielded yellow crystals (5 mg), m.p. 265–267 °C. The molecular weight was determined by orbitrap ESI-MS/MS with a mass spectrometer (Q-exactive Focus, Bremen, Germany) [M-H]−: 359.0771, calcd. for C18H17O8−: 359.0772. 1H-NMR (Bruker Avance 300 MHz, DMSO-d6) δ ppm: 7.65(1H, d, J = 1.4 Hz, H-2′), 7.55(1H, dd, J = 1.4, 8.4 Hz, H-6′), 6.97(1H, d, J = 8.4 Hz, H-5′), 6.43(1H, s, H-6), 3.90(3H, s, OCH3), 3.93(3H, s, OCH3), 3.86(3H, s, OCH3). 13C-NMR (Bruker Avance 300 MHz, DMSO-d6) δ ppm: 147.92 (C-2), 137.23 (C-3), 177.35 (C-4), 162.54 (C-5), 99.35 (C-6), 165.74 (C-7), 163.2 (C-8), 158.2 (C-9), 104.4 (C-10), 124.13 (C-1), 116.06 (C-2′), 146.23 (C-3′), 148.75 (C-4′), 116.23 (C-5′), 121.66 (C-6′), 56.92 (O-CH3), 56.90 (O-CH3), 56.95 (O-CH3).

Experimental details

H atoms were located in the difference Fourier map, but refined with fixed individual displacement parameters, using a riding mode with C—H distances of 0.93 Å (for aromatic rings), 0.96 Å (for CH3), with Uiso(H) values of 1.2Ueq(C) (for CH in aromatic), and 1.5Ueq(C) (for methyl group), O—H distances are 0.82 Å with Uiso(H) values of 1.5Ueq(O).

Discussion

The core system of the title compound is planar (r.m.s. deviation 0.072 Å), excluding the methyl groups C16 and C17. The molecular structure is stabilized by an intramolecular hydrogen bond, O4—H4⋯O5. In the crystal packing all hydroxyl groups participate as donor and acceptor of intermolecular hydrogen bonds interactions. In total different set-graphs motifs such as chains and rings are present [14]. The packing also features π–π stacking interactions between benzene rings [centroid–centroid distance = 3.701(2) Å]. All distances and angles are in the normal range.

Acknowledgements

The authors thank FONDECYT (Chile) (Grant 1140178) for financial support. IB Thanks to Fondequip (EQM13–0021).

References

1. Brito, I.; Simirgiotis, M. J.; Brito, A.; Werner, M. R.; Bórquez, J.; Winterhalter, P.; Cárdenas, A.: A non-centrosymmetric polymorph of 5-hydroxy-7-methoxy-2-phenylchroman-4-one. J. Chil. Chem. Soc. 60 (2015) 2864–2866.10.4067/S0717-97072015000100020Search in Google Scholar

2. Brito, I.; Bórquez, J.; Simirgiotis, M.; Neves-Vieira, M.; Jerz, G.; Winterhalter, P.; Bolte, M.; Cárdenas, A.: Crystal structure of 2-nor-1,2-secolycoserone, C24H32O 4. Z. Kristallogr. − NCS. 229 (2014) 399–400.10.1515/ncrs-2014-0212Search in Google Scholar

3. Bórquez, J.; Ardiles, A.; Loyola, L. A.; Peña-Rodriguez, L. M.; Molina-Salinas, G. M.; Vallejos, J.; Collado, I. G.; Simirgiotis, M. J.: Further mulinane and azorellane diterpenoids isolated from mulinum crassifolium and azorella compacta. Molecules 19 (2014) 3898–3908.10.3390/molecules19043898Search in Google Scholar

4. Bórquez, J.; Bartolucci, N. L.; Echiburú-Chau, C.; Winterhalter, P.; Vallejos, J.; Jerz, G.; Simirgiotis, M. J.: Isolation of cytotoxic diterpenoids from the Chilean medicinal plant Azorella compacta Phil from the Atacama Desert by high–speed counter–current chromatography. J. Sci. Food Agric. 96 (2016) 2832–2838.10.1002/jsfa.7451Search in Google Scholar

5. Bohlmann, F.; Fritz, U.; King, R. M.: Neue tremeton-derivate aus Parastrephia lepidophylla. Phytochemistry. 18 (1979) 1403–1405.10.1016/0031-9422(79)83037-XSearch in Google Scholar

6. Pan, L.; Li, X.-Z.; Yan, Z.-Q.; Guo, H.-R.; Qin, B.: Phytotoxicity of umbelliferone and its analogs: Structure–activity relationships and action mechanisms. Plant Physiol. Biochem. 97 (2015) 272–277.10.1016/j.plaphy.2015.10.020Search in Google Scholar PubMed

7. Yoo, H.; Kim, S. H.; Lee, J.; Kim, H. J.; Seo, S. H.; Chung, B. Y.; Jin, C.; Lee, Y. S.: Synthesis and antioxidant activity of 3-methoxyflavones. Bull. Korean Chem. Soc. 26 (2005) 2057–2060.10.1002/chin.200616142Search in Google Scholar

8. Agrawal, P. K.: Carbon-13 NMR of flavonoids. Elsevier: Michigan, 1989; p 564.10.1016/B978-0-444-87449-8.50011-0Search in Google Scholar

9. Modak, B.; Rojas, M.; Torres, R.: Chemical Analysis of the Resinous Exudate Isolated fromHeliotropium taltalenseand Evaluation of the Antioxidant Activity of the Phenolics Components and the Resin in Homogeneous and Heterogeneous Systems. Molecules 14 (2009) 1980–1989.10.3390/molecules14061980Search in Google Scholar PubMed PubMed Central

10. Sheldrick, G. M.: Crystal structure refinement with SHELXL. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053229614024218Search in Google Scholar PubMed PubMed Central

11. Bruker. APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA, 2007.Search in Google Scholar

12. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A. K.; Puschmann, H.: OLEX2: a complete structure solution, refinement and analysis program. J. Appl. Cryst. 42 (2009) 339–341.10.1107/S0021889808042726Search in Google Scholar

13. Spek, A. L.: Structure validation in chemical crystallography. Acta Crystallogr. D65 (2009) 148–155.10.1107/S090744490804362XSearch in Google Scholar PubMed PubMed Central

14. Bernstein, J.; Davis, R. E.; Shimoni, L.; Chang, N.-L.: Patterns in hydrogen bonding: functionality and graph set analysis in crystals. Angew. Chem. Int. Ed. 34 (1995) 1555–1573.10.1002/anie.199515551Search in Google Scholar

Received: 2016-7-22
Accepted: 2017-1-7
Published Online: 2017-2-7
Published in Print: 2017-3-1

©2017 Iván Brito et al., published by De Gruyter.

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Articles in the same Issue

  1. Cover and Frontmatter
  2. The crystal structure of triphenylphosphineoxide – 2,5-dichloro-3,6-dihydroxycyclohexa-2,5-diene-1,4-dione (2/1), C42H32Cl2O6P2
  3. Crystal structure of poly-[diaqua-[bis(μ2-hydroxy)-bis(μ4-3,4,5,6-tetrachlorophthalato-κ3O,O′:O′; κ2O′′:O′′′)dilanthanum(III)], C8H3Cl4LaO6
  4. Crystal structure of 1,1′-(3,4-diphenylthieno[2,3-b]thiophene-2,5-diyl)bis[1-phenyl-methanone], C32H20O2S2
  5. Crystal structure of 4a-hydroxy-9-(3,5-dibromo-phenyl)-3,4,4a,5,6,7,9,9a-octahydro-2H-xanthene-1,8-dione, C19H18Br2O4
  6. Crystal structure of 5-hydroxy-4,6,9,10-tetramethyl-1-oxo-6-vinyldecahydro-3a,9-propanocyclopenta[8]annulen-8-yl 2-((2-methyl-1-(3-methylbenzamido)propan-2-yl)thio)acetate, C34H49NO5S
  7. Crystal structure of pyridinium bis(naphthalane-2,3-diolato-κ2O,O′)borate monohydrate, C25H20BNO5
  8. Crystal structure of 1,1′-((1E,1′E)-(((ethane-1,2-diylbis(oxy))bis(2,1-phenylene))bis(azanylylidene))bis(methanylylidene))bis(naphthalen-2-olato)nickel(II), C72H52N4O8Ni2
  9. The crystal structure of 3-(2-acetyl-4-butyramido-phenoxy)-2-hydroxy-N-isopropylpropan-1-aminium tetraphenylborate, C42H49BN2O4
  10. Crystal structure of 4-bromobenzyl (Z)-N′-(adamantan-1-yl)-4-phenylpiperazine-1-carbothioimidate, C28H34BrN3S
  11. Crystal structure of poly-[(μ6-benzene-1,2,4,5-tetracarboxylato)-(μ2-1,2-bis(imidazol-1-ylmethyl)benzene)dicobalt(II)], Co2C24H16N4O8
  12. Crystal structure of catena-(bis(μ2-1, 2-bis(imidazole-1-ylmethyl)benzene-κN:N′)-dichlororido-nickel(II)), C28H28Cl2N8Ni
  13. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxy-3-(4-methoxyphenyl)prop-2-en-1-one, C15H16N2O3
  14. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxy-3-phenylprop-2-en-1-one, C14H14N2O2
  15. Crystal structure of (E)-2-(4-hydroxy-3-methoxybenzylidene)-6-methoxy-3,4-dihydronaphthalen-1(2H)-one, C19H18O4
  16. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-(4-ethoxyphenyl)-3-hydroxyprop-2-en-1-one, C16H18N2O3
  17. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxy-3-(p-toly)prop-2-en-1-one, C15H16N2O2
  18. Crystal structure of 1-acetyl-3-(3-chlorophenyl)-5-(4-isopropylphenyl)-4,5-dihydro-(1H)-pyrazole, C20H21ClN2O
  19. The crystal structure of 1-methyl-2,4-dinitro-5-iodoimidazole, C4H3IN4O4
  20. The crystal structure of 4-chloro-3,5-dinitroaniline, C6H4ClN3O4
  21. Crystal structure of N,N-dimethyl-N′-(2-methyl-4-oxo-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-3(4H)-yl)formimidamide, C14H18N4OS
  22. Crystal structure of tetrakis(μ2-acetato-κ2O:O′)-bis[μ3-4-chloro-2,6-bis((methylimino)methyl)phenolato-κ2N,O:O,N′]-(μ4-oxido)tetracopper(II), C28H32Cl2Cu4N4O11
  23. Crystal structure of catena-poly[diaqua-bis(μ2-ethane-1,2-diyl-bis(pyridine-3-carboxylate-κ2N:N′))copper(II)] dinitrate, C28H28CuN6O16
  24. Synthesis and crystal structure of catena-poly[(μ2-nicotinato-κ2O,O′: κ1N)-(nitrato-κ1O)-(bis(2-benzimidazol-ylmethyl)amine-κ3N,N′,N′′)lead(II)], C22H18N7O5Pb
  25. The twinned crystal structure of (4SR)-7-benzyl-2,4,8,8-tetramethyl-7,8-dihydroimidazo[5,1-c][1,2,4]triazine-3,6(2H,4H)-dione, C16H20N4O2
  26. Crystal structure of (Z)-3-hydroxy-3-(4-methoxyphenyl)-1-(pyridin-2-yl)prop-2-en-1-one, C15H13NO3
  27. Crystal structure of 2-amino-4-(2,3-dichlorophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C16H12Cl2N2O2
  28. Crystal structure of catena-poly[(μ2-butane-1,4-diyl-bis(pyridine-3-carboxylato-κN))silver(I)] tetrafluoroborate, C16H16AgN2O4BF4
  29. Crystal structure of poly[diaqua-(1,10-phenanthroline-κ2N,N′)-(μ2-2,5-dihydroxytere-phthalato)-bis(μ4-2,5-dihydroxyterephthalato)dicerium(III)], C24H16CeN2O10
  30. Crystal structure of 5,7,4′-trihydroxy-3,8,3′-trymethoxyflavone, C18H16O8
  31. Crystal structure of N-(3,4-dichlorobenzylidene)-4-methylaniline, C14H11Cl2N
  32. Crystal structure of 4-(3-Methoxy-phenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylic acid ethyl ester, C22H27NO4
  33. Crystal structure of 2-amino-4-(3-fluorophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C16H13FN2O2
  34. Crystal structure of 1,1,(3,4-dihydroxythieno[2,3-b] thiophene-2,5-diyl)bis(2-bromoethanone), C10H6Br2O4S2
  35. The crystal structure of N,N′-(4,4′-oxydibenzyl)-bisisonicotinamide 3.5 hydrate, C24H24N4O6
  36. Crystal structure of catena-poly[hexakis(μ2-chlorido)-hexakis(4-(1H-pyrazol-5-yl)pyridine-κN)tricadmium(II)], Cd3C48H42Cl6N18
  37. Crystal structure of 2-(4-(dimethylamino)phenyl)-1,3-dimethyl-1H-perimidin-3-ium iodide, C21H22I1N3
  38. Crystal structure of 4-(1,3-dimethyl-2,3-dihydro-1H-perimidin-2-yl)benzonitrile, C20H17N3
  39. Crystal structure of tetrakis(μ2-acetato-κ2O:O′)-bis(2,2′-sulfonyldipyrazine-κ1N)dicopper(II), C24H24Cu2N8O12S2
  40. Crystal structure of 1-(4-chlorophenyl)-6,8-diphenyl-1H-pyrazolo[4,3-c]quinoline, C28H18ClN3
  41. Crystal structure of methyl 3-((1-(2-(methoxycarbonyl)benzyl)-1H-1,2,3-triazol-4-yl)methoxy)-2-naphthoate, C24H21N3O5
  42. Crystal structure of (tris(2-pyridylmethyl)amine-κ4N,N′,N′′,N′′′′)-chloranilato-κO,O′-zinc(II) – methanol (1/1), C25H22Cl2N4O5Zn
  43. Crystal structure of 1,1-dimethyl-3-(4-methoxyphenyl)urea, C10H14N2O2
  44. Crystal structure of 4a-Hydroxy-9-(2-nitro-phenyl)-3,4,4a,5,6,7,9,9a-octahydro-2H-xanthene-1,8-dione, C19H19NO6
  45. Crystal structure of chlorido-(η6–1-isopropyl-4-methyl benzene)-(1-(pyridin-2-yl)-N-(p-tolyl)methanimine-κ2N,N′)ruthenium(II) hexafluorophosphate(V), C23H26ClF6N2PRu
  46. Crystal structure of phenyl(2-phenyl-2,3-dihydro-1H-perimidin-2-yl)methanone, C24H18N2O
  47. Crystal structure of (E)-3-methyl-4-((3-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-4-yl)methylene)-1-phenyl-1H-pyrazol-5(4H)-one, C29H23N7O
  48. Crystal structure of 2-(4-(2-butyl-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-6-yl)piperazin-1-yl)-2-oxoethyldiethylcarbamodithioate, C27H34N4O3S2
  49. Crystal structure of poly-[diaqua-bis(μ-4,4′-bipyridine-κ2N:N′)cobalt(II)] bis(4-chlorobenzenesulfonate) – 4,4′-bipyridine – water (1/1/2), C42H40Cl2CoN6O10S2
  50. Crystal structure of (η6-benzene)-(N-(2,6-dimethylphenyl)-1-(pyridin-2-yl)methanimine-κ2N,N′)ruthenium(II) perchlorate monohydrate, C20H20Cl2N2O5Ru
  51. Crystal structure of 4,10,16,22-tetrahydroxy-6,12,18,24-tetramethoxy-2,8,14,20-tetraethylphenylresorcin[4]arene – ethyl acetate (1/1), C68H72O10
  52. Crystal structure of chlorido-(N-(2,5-dichlorophenyl)-1-(pyridin-2-yl)methanimine-κ2N,N′)(η6-1-isopropyl-4-methyl benzene) ruthenium (II) tetrafluoroborate, C22H22Cl3N2BF4Ru
  53. Crystal structure of 3-(5-methyl-1-p-tolyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde, a rare Z′ = 3 structure, C20H17N5O
  54. Crystal structure of 5-(5-(4-chlorophenyl)-1-phenyl-1H-pyrazol-3-yl)-N-phenyl-1,3,4-thiadiazol-2-amine, C23H16ClN5S
  55. Crystal structure of 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one-N,N-dimethylformamide (1/1), C18H17NO5
  56. Crystal structure of halogen-bonded 2-chloro-1,10-phenanthroline—1,4-diiodotetrafluorobenzene (2/1), C30H14Cl2F4I2N4
  57. Crystal structure of 1-(4,4-dimethyl-2,6-dithioxo-1,3,5-triazinan-1-yl)-3-(diethylaminocarbonyl)thiourea, C11H20N6OS3
  58. Crystal structure of methyl 1-(4-fluorobenzyl)-3-phenyl-1H-pyrazole-5-carboxylate, C18H15FN2O2
  59. Crystal structure of 1,1-dimethyl-3-(4-methylphenyl)urea, C10H14N2O
  60. Crystal structure of yttrium gallium antimonide, Y5Ga1.24Sb2.77
  61. Crystal structure of 2-(bis(4-methoxyphenyl)amino)-2-oxoacetic acid, C16H15NO5
https://doi.org/10.1515/ncrs-2016-0224
Creative Commons
BY-NC-ND 3.0

Articles in the same Issue

  1. Cover and Frontmatter
  2. The crystal structure of triphenylphosphineoxide – 2,5-dichloro-3,6-dihydroxycyclohexa-2,5-diene-1,4-dione (2/1), C42H32Cl2O6P2
  3. Crystal structure of poly-[diaqua-[bis(μ2-hydroxy)-bis(μ4-3,4,5,6-tetrachlorophthalato-κ3O,O′:O′; κ2O′′:O′′′)dilanthanum(III)], C8H3Cl4LaO6
  4. Crystal structure of 1,1′-(3,4-diphenylthieno[2,3-b]thiophene-2,5-diyl)bis[1-phenyl-methanone], C32H20O2S2
  5. Crystal structure of 4a-hydroxy-9-(3,5-dibromo-phenyl)-3,4,4a,5,6,7,9,9a-octahydro-2H-xanthene-1,8-dione, C19H18Br2O4
  6. Crystal structure of 5-hydroxy-4,6,9,10-tetramethyl-1-oxo-6-vinyldecahydro-3a,9-propanocyclopenta[8]annulen-8-yl 2-((2-methyl-1-(3-methylbenzamido)propan-2-yl)thio)acetate, C34H49NO5S
  7. Crystal structure of pyridinium bis(naphthalane-2,3-diolato-κ2O,O′)borate monohydrate, C25H20BNO5
  8. Crystal structure of 1,1′-((1E,1′E)-(((ethane-1,2-diylbis(oxy))bis(2,1-phenylene))bis(azanylylidene))bis(methanylylidene))bis(naphthalen-2-olato)nickel(II), C72H52N4O8Ni2
  9. The crystal structure of 3-(2-acetyl-4-butyramido-phenoxy)-2-hydroxy-N-isopropylpropan-1-aminium tetraphenylborate, C42H49BN2O4
  10. Crystal structure of 4-bromobenzyl (Z)-N′-(adamantan-1-yl)-4-phenylpiperazine-1-carbothioimidate, C28H34BrN3S
  11. Crystal structure of poly-[(μ6-benzene-1,2,4,5-tetracarboxylato)-(μ2-1,2-bis(imidazol-1-ylmethyl)benzene)dicobalt(II)], Co2C24H16N4O8
  12. Crystal structure of catena-(bis(μ2-1, 2-bis(imidazole-1-ylmethyl)benzene-κN:N′)-dichlororido-nickel(II)), C28H28Cl2N8Ni
  13. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxy-3-(4-methoxyphenyl)prop-2-en-1-one, C15H16N2O3
  14. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxy-3-phenylprop-2-en-1-one, C14H14N2O2
  15. Crystal structure of (E)-2-(4-hydroxy-3-methoxybenzylidene)-6-methoxy-3,4-dihydronaphthalen-1(2H)-one, C19H18O4
  16. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-(4-ethoxyphenyl)-3-hydroxyprop-2-en-1-one, C16H18N2O3
  17. Crystal structure of (Z)-1-(1,5-dimethyl-1H-pyrazol-3-yl)-3-hydroxy-3-(p-toly)prop-2-en-1-one, C15H16N2O2
  18. Crystal structure of 1-acetyl-3-(3-chlorophenyl)-5-(4-isopropylphenyl)-4,5-dihydro-(1H)-pyrazole, C20H21ClN2O
  19. The crystal structure of 1-methyl-2,4-dinitro-5-iodoimidazole, C4H3IN4O4
  20. The crystal structure of 4-chloro-3,5-dinitroaniline, C6H4ClN3O4
  21. Crystal structure of N,N-dimethyl-N′-(2-methyl-4-oxo-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidin-3(4H)-yl)formimidamide, C14H18N4OS
  22. Crystal structure of tetrakis(μ2-acetato-κ2O:O′)-bis[μ3-4-chloro-2,6-bis((methylimino)methyl)phenolato-κ2N,O:O,N′]-(μ4-oxido)tetracopper(II), C28H32Cl2Cu4N4O11
  23. Crystal structure of catena-poly[diaqua-bis(μ2-ethane-1,2-diyl-bis(pyridine-3-carboxylate-κ2N:N′))copper(II)] dinitrate, C28H28CuN6O16
  24. Synthesis and crystal structure of catena-poly[(μ2-nicotinato-κ2O,O′: κ1N)-(nitrato-κ1O)-(bis(2-benzimidazol-ylmethyl)amine-κ3N,N′,N′′)lead(II)], C22H18N7O5Pb
  25. The twinned crystal structure of (4SR)-7-benzyl-2,4,8,8-tetramethyl-7,8-dihydroimidazo[5,1-c][1,2,4]triazine-3,6(2H,4H)-dione, C16H20N4O2
  26. Crystal structure of (Z)-3-hydroxy-3-(4-methoxyphenyl)-1-(pyridin-2-yl)prop-2-en-1-one, C15H13NO3
  27. Crystal structure of 2-amino-4-(2,3-dichlorophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C16H12Cl2N2O2
  28. Crystal structure of catena-poly[(μ2-butane-1,4-diyl-bis(pyridine-3-carboxylato-κN))silver(I)] tetrafluoroborate, C16H16AgN2O4BF4
  29. Crystal structure of poly[diaqua-(1,10-phenanthroline-κ2N,N′)-(μ2-2,5-dihydroxytere-phthalato)-bis(μ4-2,5-dihydroxyterephthalato)dicerium(III)], C24H16CeN2O10
  30. Crystal structure of 5,7,4′-trihydroxy-3,8,3′-trymethoxyflavone, C18H16O8
  31. Crystal structure of N-(3,4-dichlorobenzylidene)-4-methylaniline, C14H11Cl2N
  32. Crystal structure of 4-(3-Methoxy-phenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylic acid ethyl ester, C22H27NO4
  33. Crystal structure of 2-amino-4-(3-fluorophenyl)-5-oxo-5,6,7,8-tetrahydro-4H-chromene-3-carbonitrile, C16H13FN2O2
  34. Crystal structure of 1,1,(3,4-dihydroxythieno[2,3-b] thiophene-2,5-diyl)bis(2-bromoethanone), C10H6Br2O4S2
  35. The crystal structure of N,N′-(4,4′-oxydibenzyl)-bisisonicotinamide 3.5 hydrate, C24H24N4O6
  36. Crystal structure of catena-poly[hexakis(μ2-chlorido)-hexakis(4-(1H-pyrazol-5-yl)pyridine-κN)tricadmium(II)], Cd3C48H42Cl6N18
  37. Crystal structure of 2-(4-(dimethylamino)phenyl)-1,3-dimethyl-1H-perimidin-3-ium iodide, C21H22I1N3
  38. Crystal structure of 4-(1,3-dimethyl-2,3-dihydro-1H-perimidin-2-yl)benzonitrile, C20H17N3
  39. Crystal structure of tetrakis(μ2-acetato-κ2O:O′)-bis(2,2′-sulfonyldipyrazine-κ1N)dicopper(II), C24H24Cu2N8O12S2
  40. Crystal structure of 1-(4-chlorophenyl)-6,8-diphenyl-1H-pyrazolo[4,3-c]quinoline, C28H18ClN3
  41. Crystal structure of methyl 3-((1-(2-(methoxycarbonyl)benzyl)-1H-1,2,3-triazol-4-yl)methoxy)-2-naphthoate, C24H21N3O5
  42. Crystal structure of (tris(2-pyridylmethyl)amine-κ4N,N′,N′′,N′′′′)-chloranilato-κO,O′-zinc(II) – methanol (1/1), C25H22Cl2N4O5Zn
  43. Crystal structure of 1,1-dimethyl-3-(4-methoxyphenyl)urea, C10H14N2O2
  44. Crystal structure of 4a-Hydroxy-9-(2-nitro-phenyl)-3,4,4a,5,6,7,9,9a-octahydro-2H-xanthene-1,8-dione, C19H19NO6
  45. Crystal structure of chlorido-(η6–1-isopropyl-4-methyl benzene)-(1-(pyridin-2-yl)-N-(p-tolyl)methanimine-κ2N,N′)ruthenium(II) hexafluorophosphate(V), C23H26ClF6N2PRu
  46. Crystal structure of phenyl(2-phenyl-2,3-dihydro-1H-perimidin-2-yl)methanone, C24H18N2O
  47. Crystal structure of (E)-3-methyl-4-((3-(5-methyl-1-phenyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-4-yl)methylene)-1-phenyl-1H-pyrazol-5(4H)-one, C29H23N7O
  48. Crystal structure of 2-(4-(2-butyl-1,3-dioxo-2,3-dihydro-1H-benzo[de]isoquinolin-6-yl)piperazin-1-yl)-2-oxoethyldiethylcarbamodithioate, C27H34N4O3S2
  49. Crystal structure of poly-[diaqua-bis(μ-4,4′-bipyridine-κ2N:N′)cobalt(II)] bis(4-chlorobenzenesulfonate) – 4,4′-bipyridine – water (1/1/2), C42H40Cl2CoN6O10S2
  50. Crystal structure of (η6-benzene)-(N-(2,6-dimethylphenyl)-1-(pyridin-2-yl)methanimine-κ2N,N′)ruthenium(II) perchlorate monohydrate, C20H20Cl2N2O5Ru
  51. Crystal structure of 4,10,16,22-tetrahydroxy-6,12,18,24-tetramethoxy-2,8,14,20-tetraethylphenylresorcin[4]arene – ethyl acetate (1/1), C68H72O10
  52. Crystal structure of chlorido-(N-(2,5-dichlorophenyl)-1-(pyridin-2-yl)methanimine-κ2N,N′)(η6-1-isopropyl-4-methyl benzene) ruthenium (II) tetrafluoroborate, C22H22Cl3N2BF4Ru
  53. Crystal structure of 3-(5-methyl-1-p-tolyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazole-4-carbaldehyde, a rare Z′ = 3 structure, C20H17N5O
  54. Crystal structure of 5-(5-(4-chlorophenyl)-1-phenyl-1H-pyrazol-3-yl)-N-phenyl-1,3,4-thiadiazol-2-amine, C23H16ClN5S
  55. Crystal structure of 7-hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one-N,N-dimethylformamide (1/1), C18H17NO5
  56. Crystal structure of halogen-bonded 2-chloro-1,10-phenanthroline—1,4-diiodotetrafluorobenzene (2/1), C30H14Cl2F4I2N4
  57. Crystal structure of 1-(4,4-dimethyl-2,6-dithioxo-1,3,5-triazinan-1-yl)-3-(diethylaminocarbonyl)thiourea, C11H20N6OS3
  58. Crystal structure of methyl 1-(4-fluorobenzyl)-3-phenyl-1H-pyrazole-5-carboxylate, C18H15FN2O2
  59. Crystal structure of 1,1-dimethyl-3-(4-methylphenyl)urea, C10H14N2O
  60. Crystal structure of yttrium gallium antimonide, Y5Ga1.24Sb2.77
  61. Crystal structure of 2-(bis(4-methoxyphenyl)amino)-2-oxoacetic acid, C16H15NO5
Downloaded on 29.4.2026 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2016-0224/html?lang=en
Scroll to top button